Database for metabolic surgery outcomes at Beijing Friendship Hospital
Beijing Friendship Hospital Metabolic Surgery Clinical Database
This study is collecting information from patients who have had metabolic surgery at Beijing Friendship Hospital to see how well it works for treating obesity-related health issues like type 2 diabetes and high blood pressure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Sex | All |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT03520699 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze data from patients undergoing metabolic surgery at Beijing Friendship Hospital. It focuses on understanding the efficacy and safety of metabolic surgery in treating obesity-related metabolic diseases, such as type 2 diabetes and hypertension, among Chinese patients. By gathering a larger sample size and extending the observation period, the study seeks to provide valuable insights into the long-term benefits of metabolic surgery. The findings may help inform future research and clinical practices in this field.
Who should consider this trial
Good fit: Ideal candidates for this study are severely obese patients who are eligible for metabolic surgery, such as laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB).
Not a fit: Patients who cannot understand or are unwilling to participate in the registry will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of metabolic surgery's effectiveness in improving health outcomes for obese patients.
How similar studies have performed: Other studies have shown promising results regarding the efficacy of metabolic surgery in treating obesity-related conditions, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * be able to receive metabolic surgery (LSG or LRYGB) Exclusion Criteria: * can not be able to understand and willing to participate in this registry with signature
Where this trial is running
Beijing
- Beijing Friendship Hospital — Beijing, China (Recruiting)
Study contacts
- Principal investigator: Zhongtao Zhang, M.D. — Beijing Friendship Hospital
- Study coordinator: Zhongtao Zhang, M.D.
- Email: zhangzht@ccmu.edu.cn
- Phone: +86-13801060364
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.